Inside The Mentoring Round, CFO David Snyder of Coya Therapeutics stresses that biotech companies must not get sidetracked by short-term valuations or minor gains but should focus on the bigger picture of achieving substantial market capitalization. This perspective is grounded in the understanding that success in biotech often hinges on the ability to finance a […]
968: From the Investor’s Point of View | David Snyder, CFO, Coya Therapeutics
It was the type of introduction that any MBA student would envy, and one at which David Snyder, 35 years later, still marvels. Back in the late 1980s, a business school classmate introduced him to notable investor and billionaire tycoon Sam Zell, who subsequently offered Snyder a job. Without hesitation, Snyder accepted Zell's offer and…
Listen to the Episode Below (0:57:30)